Lipid and inflammatory biomarker profiles in patients receiving tocilizumab for rheumatoid arthritis: Analysis of five phase 3 clinical trials Genovese, M. C., Smolen, J. S., Emery, P., Jones, G., Lee, J. S., Alecock, E., Kremer, J. M. WILEY-LISS. 2008: S531–S532

View details for Web of Science ID 000259244201247